drugset / Trial / NCT00645177
Phase 2 Study of ABT-869 in Combination With Paclitaxel Versus Paclitaxel Alone to Treat Metastatic Breast Cancer
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine the effect of ABT-869 plus paclitaxel compared to paclitaxel alone on disease progression in metastatic breast cancer.
Timeline
- Start
- 2008-07
- Primary completion
- 2009-12
- Completion
- 2009-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | ABT-869 | Unknown | 0.2 mg/kg | Oral |
| Comparator | Paclitaxel | Small molecule | 90 mg/m2 | Intravenous |